NOCIL (NOCIL)₹138.05−0.98%Specialty Chemicals
In the Sep 2026 quarter (consolidated), NOCIL reported sales of ₹426 Cr, up 32.9% from Sep 2025, and net profit of ₹23.91 Cr, up 100.1% year on year. For the year to Mar 2026, sales were ₹1,301 Cr and net profit ₹55.75 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 340 | 355 | 371 | 362 | 317 | 339 | 335 | 321 | 316 | 329 | 402 | 426 |
| Expenses | 292 | 313 | 331 | 326 | 294 | 305 | 307 | 298 | 289 | 310 | 358 | 392 |
| Operating Profit | 48.85 | 44.84 | 40.89 | 37.86 | 23.91 | 33.92 | 30.90 | 21.95 | 26.91 | 20.95 | 44.86 | 35.88 |
| OPM % | 14.0% | 13.0% | 11.0% | 10.0% | 8.0% | 10.0% | 9.0% | 7.0% | 8.0% | 6.0% | 11.0% | 8.0% |
| Other Income | 6.01 | 25.01 | 9.01 | 8.01 | 9.01 | 6.01 | 7.01 | 10.01 | 1.01 | 14.02 | 6.01 | 7.01 |
| Interest | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 12.95 | 12.95 | 12.97 | 12.97 | 13.96 | 12.95 | 13.95 | 13.96 | 13.96 | 13.96 | 13.96 | 13.95 |
| Profit before tax | 40.96 | 55.99 | 36.95 | 31.98 | 18.99 | 25.97 | 22.96 | 18.98 | 12.99 | 20.97 | 36.98 | 27.96 |
| Tax % | 26.0% | 25.0% | 26.0% | −30.0% | 32.0% | 20.0% | 25.0% | 35.0% | 31.0% | 19.0% | 25.0% | 15.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −2.99 | 0.00 | 0.00 | 0.00 |
| Net Profit | 29.86 | 41.84 | 26.91 | 41.82 | 12.94 | 20.91 | 16.93 | 11.95 | 8.96 | 16.92 | 27.91 | 23.91 |
| EPS (Rs) | 1.79 | 2.48 | 1.61 | 2.51 | 0.76 | 1.23 | 1.02 | 0.72 | 0.54 | 1.01 | 1.65 | 1.43 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 714 | 740 | 961 | 1,041 | 845 | 923 | 1,568 | 1,614 | 1,442 | 1,390 | 1,301 | 1,473 |
| Expenses | 576 | 583 | 696 | 751 | 669 | 795 | 1,287 | 1,366 | 1,252 | 1,256 | 1,205 | 1,349 |
| Operating Profit | 139 | 159 | 268 | 292 | 177 | 131 | 287 | 252 | 194 | 137 | 101 | 129 |
| OPM % | 20.0% | 22.0% | 28.0% | 28.0% | 21.0% | 14.0% | 18.0% | 16.0% | 14.0% | 10.0% | 8.0% | 8.7% |
| Other Income | 3.01 | 9.01 | 11.01 | 10.01 | 9.01 | 14.02 | 2.01 | 6.01 | 39.01 | 32.01 | 31.04 | 28.05 |
| Interest | 9.01 | 2.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 | 2.01 | 1.01 | 0.00 |
| Depreciation | 14.95 | 19.93 | 23.92 | 23.93 | 33.91 | 36.90 | 47.88 | 55.78 | 52.81 | 53.81 | 54.85 | 55.83 |
| Profit before tax | 119 | 147 | 255 | 278 | 152 | 107 | 241 | 202 | 180 | 114 | 75.89 | 98.90 |
| Tax % | 34.0% | 34.0% | 33.0% | 33.0% | 14.0% | 17.0% | 27.0% | 26.0% | 26.0% | 10.0% | 27.0% | — |
| Exceptional items | 0.00 | 0.00 | −1.99 | 1.99 | 2.99 | 0.99 | 0.00 | 0.99 | 15.95 | 10.97 | 9.97 | −2.99 |
| Net Profit | 77.73 | 96.62 | 169 | 184 | 130 | 87.63 | 175 | 149 | 133 | 103 | 55.75 | 77.70 |
| EPS (Rs) | 4.86 | 5.92 | 10.31 | 11.14 | 7.87 | 5.31 | 10.53 | 8.92 | 7.95 | 6.15 | 3.32 | 4.63 |
| Dividend payout % | 25.1% | 30.0% | 24.1% | 22.0% | 32.0% | 38.1% | 28.1% | 34.1% | 38.1% | 32.0% | 45.1% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 161 | 161 | 164 | 164 | 165 | 167 | 166 | 167 | 167 | 168 | 167 | 167 |
| Reserves | 254 | 309 | 749 | 881 | 998 | 1,020 | 1,119 | 1,277 | 1,383 | 1,531 | 1,595 | 1,605 |
| Borrowings | 147 | 26.08 | 15.04 | 5.01 | 0.00 | 7.01 | 6.01 | 6.01 | 10.02 | 13.02 | 10.02 | 8.02 |
| Other Liabilities | 193 | 186 | 233 | 279 | 279 | 251 | 324 | 380 | 296 | 303 | 283 | 328 |
| Total Liabilities | 755 | 682 | 1,160 | 1,331 | 1,442 | 1,443 | 1,616 | 1,829 | 1,856 | 2,014 | 2,056 | 2,110 |
| Fixed Assets | 312 | 307 | 544 | 529 | 658 | 799 | 920 | 910 | 889 | 871 | 856 | 832 |
| CWIP | 3.01 | 6.02 | 4.01 | 42.11 | 131 | 157 | 14.05 | 8.02 | 9.03 | 16.05 | 60.15 | 222 |
| Investments | 21.93 | 21.92 | 176 | 280 | 130 | 53.85 | 67.75 | 52.86 | 217 | 398 | 365 | 414 |
| Other Assets | 418 | 347 | 437 | 480 | 523 | 433 | 613 | 857 | 741 | 729 | 774 | 644 |
| Inventories | 188 | 133 | 115 | 155 | 171 | 136 | 166 | 333 | 285 | 223 | 281 | 158 |
| Trade receivables | 166 | 150 | 166 | 242 | 231 | 202 | 308 | 448 | 345 | 339 | 309 | 289 |
| Cash & equivalents | 7.99 | 14.98 | 122 | 31.97 | 39.96 | 13.98 | 79.93 | 15.98 | 56.97 | 95.95 | 32.96 | 34.98 |
| Total Assets | 755 | 682 | 1,160 | 1,331 | 1,442 | 1,443 | 1,616 | 1,829 | 1,856 | 2,014 | 2,056 | 2,110 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 30.08 | 171 | 142 | 102 | 164 | 179 | 94.26 | −30.09 | 283 | 201 | 26.06 | 252 |
| Cash from investing activity | −4.98 | −11.96 | −10.96 | −140 | −101 | −106 | −57.86 | 30.91 | −216 | −76.72 | −36.87 | −211 |
| Cash from financing activity | −32.92 | −151 | −30.90 | −42.90 | −49.85 | −101 | 0.00 | −33.92 | −53.89 | −54.88 | −49.88 | −37.91 |
| Net cash flow | −7.99 | 7.98 | 101 | −81.91 | 12.99 | −27.98 | 34.96 | −32.96 | 10.98 | 67.91 | −61.93 | 1.99 |
| Capex | 8.96 | 13.94 | 12.96 | 46.78 | 236 | 179 | 26.91 | 35.87 | 29.90 | 34.86 | 123 | 174 |
| Free cash flow | 21.03 | 156 | 129 | 55.03 | −73.01 | 0.00 | 67.07 | −66.06 | 253 | 184 | −95.07 | 84.13 |
| CFO / OP % | 42.9% | 144.0% | 116.9% | 68.0% | 86.0% | 129.0% | 71.0% | 10.0% | 131.0% | 124.0% | 44.0% | 274.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 86 | 78 | 83 | 93 | 82 | 89 | 123 | 105 | 79 | 87 | 82 | 82 |
| Inventory days | 176 | 135 | 116 | 129 | 133 | 128 | 120 | 141 | 117 | 100 | 129 | 75 |
| Days payable | 79 | 74 | 82 | 96 | 77 | 84 | 123 | 91 | 52 | 53 | 54 | 72 |
| Cash conversion cycle | 183 | 139 | 117 | 126 | 139 | 133 | 120 | 155 | 144 | 134 | 157 | 85 |
| Working capital days | 72 | 87 | 87 | 95 | 100 | 105 | 115 | 129 | 109 | 111 | 131 | 92 |
| ROCE % | 18.9% | 23.9% | 21.0% | 25.9% | 25.0% | 13.0% | 9.0% | 18.0% | 12.9% | 9.9% | 6.0% | 4.0% |
For the Sep 2026 quarter, NOCIL reported sales of ₹426 Cr, up 32.9% year on year and net profit of ₹23.91 Cr, up 100.1% year on year. The operating margin was 8.0%.
NOCIL's sales for the year to Mar 2026 were ₹1,301 Cr; over the last twelve months they were ₹1,473 Cr.
Net profit for the year to Mar 2026 was ₹55.75 Cr, and ₹77.70 Cr over the last twelve months. Earnings per share over the same trailing period were ₹4.63.
NOCIL reported borrowings of ₹8.02 Cr at Mar 2026, against cash and equivalents of ₹34.98 Cr.
Cash from operations was ₹252 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹84.13 Cr.